The Return on Investment of Scaling Tuberculosis Screening and Preventive Treatment: A Modelling Study in Brazil, Georgia, Kenya, and South Africa

Juan F. Vesga, Mona Salaheldin Mohamed, Monica Shandal, Elias Jabbour, Nino Lomtadze, Mmamapudi Kubjane, Anete Trajman, Gesine Meyer-Rath, Zaza Avaliani, Wesley Rotich, Daniel Mwai, Julio Croda, Hlengani T. Mathema, Immaculate Kathure, Rhoda Pola, Fernanda Dockhorn Costa, Norbert O. Ndjeka, Maka Danelia, Maiko L. Tonini, Nelly Solomonia, Daniele M. Pelissari, Dennis Falzon, Cecily Miller, Ines Garcia Baena, Nimalan Arinaminpathy, Kevin Schwartzman, Saskia Den Boon, Jonathon R. Campbell
doi: https://doi.org/10.1101/2024.03.12.24303930

Article Information

doi 
https://doi.org/10.1101/2024.03.12.24303930
History 
  • March 14, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Juan F. Vesga, PhD1,
  2. Mona Salaheldin Mohamed, PhD2,
  3. Monica Shandal, MSc3,
  4. Elias Jabbour, MSc4,
  5. Nino Lomtadze, MD5,
  6. Mmamapudi Kubjane, PhD6,
  7. Anete Trajman, PhD7,
  8. Gesine Meyer-Rath, PhD8,
  9. Zaza Avaliani, PhD9,
  10. Wesley Rotich, MSc10,
  11. Daniel Mwai, PhD11,
  12. Julio Croda, MD12,
  13. Hlengani T. Mathema, MPH13,
  14. Immaculate Kathure, MD14,
  15. Rhoda Pola, MPH15,
  16. Fernanda Dockhorn Costa, MD16,
  17. Norbert O. Ndjeka, MMed17,
  18. Maka Danelia, PhD18,
  19. Maiko L. Tonini, PhD19,
  20. Nelly Solomonia, PhD20,
  21. Daniele M. Pelissari, PhD21,
  22. Dennis Falzon, MD22,
  23. Cecily Miller, PhD23,
  24. Ines Garcia Baena, MSc24,
  25. Nimalan Arinaminpathy, PhD25,
  26. Kevin Schwartzman, MD26,
  27. Saskia Den Boon, PhD27 and
  28. Jonathon R. Campbell, PhD28,*
  1. 1UK Health Security Agency, London, United Kingdom; School of Public Health, Imperial College London, London, United Kingdom
  2. 2Department of Medicine, McGill University, Montreal, Canada
  3. 3TB People Canada, Ottawa, Canada; Department of Economics, University of California, Santa Cruz, USA
  4. 4Department of Medicine, McGill University, Montreal, Canada
  5. 5National Center for Tuberculosis and Lung Diseases & David Tvildiani Medical University, Tbilisi. Georgia
  6. 6Health Economics and Epidemiology Research Office, University of the Witswatersand, South Africa
  7. 7Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
  8. 8Department of Global Health, Boston University, Boston, USA
  9. 9National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia
  10. 10Future Health Economics and Metrics, Nairobi, Kenya
  11. 11Future Health Economics and Metrics and University of Nairobi, Nairobi, Kenya
  12. 12Universidade Federal de Mato Grosso do Sul & Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
  13. 13National TB Control and Management Programme, Pretoria, South Africa
  14. 14National Tuberculosis, Leprosy, and Lung Disease Program, Nairobi, Kenya
  15. 15National Tuberculosis, Leprosy, and Lung Disease Program, Nairobi, Kenya
  16. 16National Tuberculosis Program, Ministry of Health, Brasilia, Brazil
  17. 17National TB Control and Management Programme, Pretoria, South Africa
  18. 18National Center for Disease Control and Public Health, Tbilisi, Georgia
  19. 19National Tuberculosis Program, Ministry of Health, Brasilia, Brazil
  20. 20National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia
  21. 21National Tuberculosis Program, Ministry of Health, Brasilia, Brazil
  22. 22World Health Organization Global TB Programme, Geneva, Switzerland
  23. 23World Health Organization Global TB Programme, Geneva, Switzerland
  24. 24World Health Organization Global TB Programme, Geneva, Switzerland
  25. 25World Health Organization Global TB Programme, Geneva, Switzerland
  26. 26Department of Medicine, McGill University, Montreal, Canada; McGill International TB Centre, Montreal, Canada; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada
  27. 27World Health Organization Global TB Programme, Geneva, Switzerland
  28. 28Department of Medicine & Department of Global and Public Health, McGill University, Montreal, Canada; McGill International TB Centre, Montreal, Canada; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada
  1. ↵*Correspondence to: Jonathon R. Campbell, McGill University, Office 3D.55, 5252 Boulevard de Maisonneuve O, Montréal, Québec, H4A 3S5. Email: jonathon.campbell{at}mcgill.ca
Back to top
Posted March 14, 2024.
Download PDF

Supplementary Material

Data/Code
Email
The Return on Investment of Scaling Tuberculosis Screening and Preventive Treatment: A Modelling Study in Brazil, Georgia, Kenya, and South Africa
Juan F. Vesga, Mona Salaheldin Mohamed, Monica Shandal, Elias Jabbour, Nino Lomtadze, Mmamapudi Kubjane, Anete Trajman, Gesine Meyer-Rath, Zaza Avaliani, Wesley Rotich, Daniel Mwai, Julio Croda, Hlengani T. Mathema, Immaculate Kathure, Rhoda Pola, Fernanda Dockhorn Costa, Norbert O. Ndjeka, Maka Danelia, Maiko L. Tonini, Nelly Solomonia, Daniele M. Pelissari, Dennis Falzon, Cecily Miller, Ines Garcia Baena, Nimalan Arinaminpathy, Kevin Schwartzman, Saskia Den Boon, Jonathon R. Campbell
medRxiv 2024.03.12.24303930; doi: https://doi.org/10.1101/2024.03.12.24303930
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area